RESEARCH TRIANGLE PARK, N.C., Jan. 9 /CNW/ -- Quintiles Transnational
Corp. today announced the appointment of Kelly McKee, M.D., as Executive
Director of Operations for the company's Public Health and Government Services
unit. McKee brings tremendous experience and expertise in infectious diseases
and vaccine product development. He will report to Oren Cohen, M.D.,
Quintiles' Chief Medical and Scientific Officer, and Head of the Public Health
and Government Services unit.
"Kelly will play an important alliance management role with government
and commercial sponsors as well as Quintiles internal resources," Cohen said.
"Our team is resourced and committed to assisting pharmaceutical and biotech
companies win government contracts to advance public health."
Prior to his appointment as Executive Director of Operations, McKee
served as Senior Director, Medical and Scientific Services (Infectious
Diseases) for Quintiles where he was responsible for providing medical support
to investigative sites. Previously, he served as Senior Director for Clinical
Research for DynPort Vaccine Company where he directed clinical trials.
McKee earned his medical degree from the University of Virginia School of
Medicine and completed his internship, residency and fellowship training in
pediatrics and pediatric infectious diseases at Vanderbilt University
Hospital. He completed a 20-year career in the U.S. Army Medical Department,
during which he completed residency training in Preventive Medicine at the
Walter Reed Army Institute of Research. McKee also earned a Master's degree
in Public Health from Johns Hopkins University School of Hygiene and Public
About Quintiles Public Health and Government Services
Quintiles Public Health and Government Services has the expertise and
experience to develop products that improve global public health and enhance
readiness to respond to bioterrorism threats, through its partnerships with
governments, non-governmental organizations (NGOs) and the biopharmaceutical
Quintiles Transnational Corp. is powering the next generation of
healthcare by providing a broad range of professional services in drug
development, financial partnering and commercialization for the biotechnology
and healthcare industries. With about 20,000 employees and offices in more
than 50 countries, it is focused on providing customer-centric solutions that
are the gold standard of the industry. For more information, please visit the
company's Web site at www.quintiles.com.
For further information:
For further information: Mari Mansfield, Media Relations, Quintiles
Transnational Corp., +1-919-998-2639 (office), +1-919-259-3298 (mobile),
firstname.lastname@example.org Web Site: http://www.quintiles.com